Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography
- 3 October 1994
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 660 (1) , 103-110
- https://doi.org/10.1016/0378-4347(94)00259-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- High-performance liquid chromatographic method for the quantitation of quinidine and selected quinidine metabolitesJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Quinidine kinetics after a single oral dose in relation to the sparteine oxidation polymorphism in man.British Journal of Clinical Pharmacology, 1990
- Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointesClinical Pharmacology & Therapeutics, 1988
- Sparteine oxidation is practically abolished in quinidine-treated patients.British Journal of Clinical Pharmacology, 1986
- Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteineEuropean Journal of Clinical Pharmacology, 1986
- Analysis of cinchona alkaloids by high-performance liquid chromatographyJournal of Chromatography A, 1984
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- Specific determination of quinidine and metabolites in biological fluids by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Determination of quinidine and metabolites in urine by reverse-phase high-pressure liquid chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Determination of Quinidine and its major metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1979